

After having other offers rejected, Canadian pharmaceutical giant Valeant made moves on Wednesday to bring their hostile takeover offer to

According to an editorial in the journal JAMA Dermatology, ″Drug Samples in Dermatology,″ pharmaceutical drug companies have been using